Home » Topics » Regulatory » Patents

Patents
RSS

Ulinastatin claimed by Mochida as skin disorder treatment

July 26, 1996

Chugai describes 24-oxo-22-oxavitamin D3 derivatives

July 26, 1996

RPR describes tachykinin NK1 antagonists

July 26, 1996

Pharmacia & Upjohn reveals non-enzymatic protein glycosylation inhibitors

July 19, 1996

Janssen describes agent for decreased intestinal motility

July 19, 1996

CJ-12954: Pfizer's anti-Helicobacter pylori compound

July 19, 1996

Glaxo Wellcome describes alpha1A-adrenoceptor antagonists

July 19, 1996

Terumo discloses fibrinogen (gpIIb/IIIa) antagonists

July 19, 1996

Platelet aggregation inhibitors from Meiji Seika

July 19, 1996

Fibrinogen antagonists from DuPont Merck

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.